<br>        Inclusion Criteria<br><br>          1. Participants with chronic renal failure on hemodialysis for = 3 months prior to<br>             randomization.<br><br>          2. On IV epoetin alfa or beta maintenance therapy continuously prescribed for a minimum<br>             of 8 weeks prior to randomization.<br><br>          3. Four consecutive hemoglobin values with a mean = 10.0 and = 12.0 g/dL during the<br>             Screening Period.<br><br>        Exclusion Criteria<br><br>          1. Females who are pregnant or breast-feeding.<br><br>          2. Known intolerance to any erythropoiesis stimulating agent or pegylated molecule or to<br>             all parenteral iron supplementation products.<br><br>          3. Known bleeding or coagulation disorder.<br><br>          4. Known hematologic disease or cause of anemia other than renal disease<br><br>          5. Poorly controlled hypertension.<br><br>          6. Evidence of active malignancy within one year prior to randomization.<br><br>          7. Temporary (untunneled) dialysis access catheter.<br><br>          8. A scheduled kidney transplant.<br><br>          9. A scheduled surgery that may be expected to lead to significant blood loss.<br>      ;<br>        Inclusion Criteria<br><br>          1. Participants with chronic renal failure on hemodialysis for = 3 months prior to<br>             randomization.<br><br>          2. On IV epoetin alfa or beta maintenance therapy continuously prescribed for a minimum<br>             of 8 weeks prior to randomization.<br><br>          3. Four consecutive hemoglobin values with a mean = 10.0 and = 12.0 g/dL during the<br>             Screening Period.<br><br>        Exclusion Criteria<br><br>          1. Females who are pregnant or breast-feeding.<br><br>          2. Known intolerance to any erythropoiesis stimulating agent or pegylated molecule or to<br>             all parenteral iron supplementation products.<br><br>          3. Known bleeding or coagulation disorder.<br><br>          4. Known hematologic disease or cause of anemia other than renal disease<br><br>          5. Poorly controlled hypertension.<br><br>          6. Evidence of active malignancy within one year prior to randomization.<br><br>          7. Temporary (untunneled) dialysis access catheter.<br><br>          8. A scheduled kidney transplant.<br><br>          9. A scheduled surgery that may be expected to lead to significant blood loss.<br>      ;<br>        Inclusion Criteria<br><br>          1. Participants with chronic renal failure on hemodialysis for = 3 months prior to<br>             randomization.<br><br>          2. On IV epoetin alfa or beta maintenance therapy continuously prescribed for a minimum<br>             of 8 weeks prior to randomization.<br><br>          3. Four consecutive hemoglobin values with a mean = 10.0 and = 12.0 g/dL during the<br>             Screening Period.<br><br>        Exclusion Criteria<br><br>          1. Females who are pregnant or breast-feeding.<br><br>          2. Known intolerance to any erythropoiesis stimulating agent or pegylated molecule or to<br>             all parenteral iron supplementation products.<br><br>          3. Known bleeding or coagulation disorder.<br><br>          4. Known hematologic disease or cause of anemia other than renal disease<br><br>          5. Poorly controlled hypertension.<br><br>          6. Evidence of active malignancy within one year prior to randomization.<br><br>          7. Temporary (untunneled) dialysis access catheter.<br><br>          8. A scheduled kidney transplant.<br><br>          9. A scheduled surgery that may be expected to lead to significant blood loss.<br>      ;<br>        Inclusion Criteria<br><br>          1. Participants with chronic renal failure on hemodialysis for = 3 months prior to<br>             randomization.<br><br>          2. On IV epoetin alfa or beta maintenance therapy continuously prescribed for a minimum<br>             of 8 weeks prior to randomization.<br><br>          3. Four consecutive hemoglobin values with a mean = 10.0 and = 12.0 g/dL during the<br>             Screening Period.<br><br>        Exclusion Criteria<br><br>          1. Females who are pregnant or breast-feeding.<br><br>          2. Known intolerance to any erythropoiesis stimulating agent or pegylated molecule or to<br>             all parenteral iron supplementation products.<br><br>          3. Known bleeding or coagulation disorder.<br><br>          4. Known hematologic disease or cause of anemia other than renal disease<br><br>          5. Poorly controlled hypertension.<br><br>          6. Evidence of active malignancy within one year prior to randomization.<br><br>          7. Temporary (untunneled) dialysis access catheter.<br><br>          8. A scheduled kidney transplant.<br><br>          9. A scheduled surgery that may be expected to lead to significant blood loss.<br>